Small Molecule Outsourcing STREAM
-
Cambrex Scientist Spotlight: Elena Bejan
1/29/2025
Holding a Ph.D. in organic chemistry from Paris-Sud University and an MBA from the Rotman School of Management, Bejan leads R&D efforts at Cambrex with a focus on scientific innovation.
-
Challenges Of Moving A Bioconjugate Candidate From Clinic To Market
Drug developers must successfully navigate the path to market, under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.
-
Improve The Bioavailability Of Poorly Soluble Drugs
3/19/2024
KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.
-
Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology
5/1/2024
Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.
-
How Drug Delivery Is Enabling A Clinical Trial For Glioblastoma
Discover highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).
-
Cambrex Scientist Spotlight: Myoung Goo Kim
1/29/2025
Myoung Goo Kim, Chemistry R&D Manager in High Point, NC, is a recognized expert in process chemistry, specializing in API manufacturing for Cambrex’s clients.
-
ADHD Awareness: How This Novel Technology Can Guide The Way
4/9/2023
Explore Nanoform's innovative nanoparticle technology and the value it can bring to molecules in development or products on the market for neurological disorders such as ADHD.
-
Considerations For Large-Scale API Production
3/1/2024
Explore expert insights on selecting the right CDMO partner for large-scale API production as well as key considerations to ensure your small molecule API program is successful.
-
Mobile Minor Process Explanation
4/28/2026
Dr. Jordan Potts explains how the Mobile Minor spray dryer works and outlines its role in spray drying and particle engineering research applications.
-
Improving Bioavailability, Drug Loads, And Pill Burdens Of Solid Dispersions
9/10/2024
Explore the pros and cons of marketed amorphous solid dispersions with so-far unpublished data as well as a green alternative to ASDs: best-in-class nanotechnology to manufacture nanocrystals.